1.11 0.00 (0.00%)

New 52W Low in past week

101.6K XNAS Volume

XNAS 24 Mar, 2025 3:37 PM (EDT)

Board Meeting
The next board meeting for FibroBiologics Inc is on 31 Mar 2025 for the purpose of FibroBiologics Inc Annual Report for 2024 See details


Insider Trading disclosures for FibroBiologics Inc

The latest disclosure was made by Garcia Ruben A. in FibroBiologics Inc where a trade of 176,200 Stock Option (Right to Buy) done was reported to US exchanges on Dec. 27, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Garcia Ruben A. General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Dec 2024 176,200 176,200 - - Stock Option (Right to Buy)
Khoja Hamid CHIEF SCIENTIFIC OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Dec 2024 176,200 176,200 - - Stock Option (Right to Buy)
O’Heeron Peter Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Dec 2024 406,339 406,339 - - Stock Option (Right to Buy)
Peter O’Heeron Director, Chief Executive Officer Gift of securities by or to the insider at price $ 0.00 per share. 09 Dec 2024 100,000 5,906,647 - 0 Common Stock
Peter O’Heeron Director, Chief Executive Officer Gift of securities by or to the insider at price $ 0.00 per share. 03 Dec 2024 50,000 6,006,647 - 0 Common Stock
Richard C. Cilento Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 5,000 5,000 - - Stock Option (Right to Buy)
Robert E. Hoffman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 5,000 5,000 - - Stock Option (Right to Buy)
Matthew Link Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 5,000 5,000 - - Stock Option (Right to Buy)
Stacy Ann Coen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 5,000 5,000 - - Stock Option (Right to Buy)
Victoria Niklas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2024 5,000 5,000 - - Stock Option (Right to Buy)
Peter O’Heeron Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.91 per share. 12 Aug 2024 8,500 6,056,647 - 1.9 16,269 Common Stock
Hamid Khoja Chief Scientific Officer Purchase of securities on an exchange or from another person at price $ 1.90 per share. 12 Aug 2024 10,000 11,250 - 1.9 19,000 Common Stock
Ruben A. Garcia General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 180,000 180,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures